Le Lézard
Classified in: Health
Subjects: MAV, POL, FVT, CFG

/R E P E A T -- Media Advisory - Minister Ralph Goodale to highlight Government support for research and innovation at the University of Saskatchewan/


SASKATOON, March 14, 2018 /CNW/ - The Honourable Ralph Goodale, Minister of Public Safety and Emergency Preparedness, will visit the University of Saskatchewan to highlight recent Government investments in safe driving, infectious diseases, sleep disorders, cancer research, and swine welfare.   

Media are invited to participate in a media availability with the Minister, University of Saskatchewan President Dr. Peter Stoicheff, and university researchers.    

 

Date:

March 15, 2018                      

Time:

11:00 a.m.   

Location:

Atrium
College of Medicine
University of Saskatchewan
107 Wiggins Road
Saskatoon, Saskatchewan S7N 5E5

           

SOURCE Canadian Institutes of Health Research


These press releases may also interest you

at 03:00
ARTHEx Biotech S.L., a clinical-stage biotechnology company focused on developing innovative medicines through the modulation of microRNAs, today announced an oral presentation at the upcoming Oligonucleotide & Peptide Therapeutics (TIDES) Conference...

at 02:32
With every successive year, the lines between medical devices and consumer electronics become increasingly blurred ? medtech companies seek to expand their reach beyond patients, and consumer electronics companies have targeted medical applications...

18 avr 2024
The 31st Canadian Cancer Society (CCS) Daffodil Ball, which took place this evening at Windsor Station in Montreal, raised $1,474,785 to fund innovative research projects and essential support programs for people living with cancer. The largest...

18 avr 2024
The report titled "Clinical Trials Matching Software Market by Functionality (Analytics & Reporting, Compliance Tracking, Data Management), Deployment (Cloud & Web Based, On-Premise), End-Use - Global Forecast 2024-2030" is now available on...

18 avr 2024
South Korea's biotechnology company Hyundai Bioscience (CEO Oh Sang-gi, www.hyundaibioscience.com) announced on April 15 that it would carry out global clinical tests aimed at treating all serotypes of Dengue virus infection....

18 avr 2024
The report titled "Progressive Familial Intrahepatic Cholestasis Treatment Market by Drug Type (Cholestyramine, Rifampicin, Ursodeoxycholic Acid), Distribution Channel (Hospital Pharmacies, Online Pharmacies, Retail Pharmacies), End-Users - Global...



News published on and distributed by: